Viridian Therapeutics: Two Products, One Commercial Buildout
Viridian Therapeutics is building a shared commercial platform for Lumvoa and investigational elegrobart in thyroid eye disease, with…
Equity Eagle NASDAQ
Viridian Therapeutics, Inc.\DE
VRDN
1 story
$2.5B Market cap · 2026-09-17
Equity Eagle 